A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries

A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries

Introduction: Vaxigrip, a trivalent split-virion, inactivated vaccine available since 1968 has been in use longer than any other influenza vaccine. It is the most widely-used influenza vaccine, with more than 1.8 billion doses distributed in more than 120 countries. Areas covered: The significant bo...

Full description

Bibliographic Details
Main Authors: Margaret Haugh, Viviane Gresset-Bourgeois, Bérengère Macabeo, Anne Woods, Sandrine I. Samson
Format: Article
Language:English
Published: Taylor & Francis Group 2017-06-01
Series:Expert Review of Vaccines
Subjects:
seasonal influenza
influenza vaccine
trivalent split-virion inactivated vaccine
vaccine efficacy
vaccine effectiveness
vaccine immunogenicity
vaccine reactogenicity
vaccine safety
Online Access:http://dx.doi.org/10.1080/14760584.2017.1324302

Internet

http://dx.doi.org/10.1080/14760584.2017.1324302

Similar Items